Gene analysis (neurotrophic receptor tyrosine kinase 1) translocation analysis
Medicare pricing data for 34 providers across 8 states
Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.
💡 What You Should Know
Gene analysis (neurotrophic receptor tyrosine kinase 1) translocation analysis (HCPCS code 81191) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $203.14, but hospitals typically charge $224.69 — a 1.1x markup. Prices vary significantly by state and provider.
🏷️ Typical Out-of-Pocket Cost
Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $203.14, your out-of-pocket cost would be approximately $40.63. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.
What Hospitals Charge vs. What Medicare Pays
Hospitals charge 1.1x more than what Medicare allows for this procedure. Medicare actually pays $203.14 on average.
Cost by State
Medicare-allowed amounts vary significantly by state
| State | Allowed Cost | Hospital Charge | Providers | Services | vs. National |
|---|---|---|---|---|---|
| Louisiana | $203 | $210 | 1 | 18 | +0.0% |
| New Jersey | $203 | $252 | 3 | 3,038 | +0.0% |
| Oklahoma | $203 | $260 | 3 | 245 | +0.0% |
| Pennsylvania | $203 | $207 | 1 | 1,106 | +0.0% |
| Texas | $203 | $212 | 12 | 6,257 | +0.0% |
| Arizona | $203 | $250 | 1 | 60 | +0.0% |
| Colorado | $203 | $911 | 1 | 14 | +0.0% |
| Florida | $203 | $223 | 11 | 2,234 | -0.0% |
⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.
💊 Need post-procedure medications? Check costs on OpenPrescriber